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Ruth Baxter1* , Jenni Murray1, Jane K. O’Hara2, Catherine Hewitt3, Gerry Richardson4, Sarah Cockayne3,
Laura Sheard3, Thomas Mills1, Rebecca Lawton1,5 and on behalf of the PACT research team
Abstract
Background: Patients, particularly older people, often experience safety issues when transitioning from hospital to
home. Although the evidence is currently equivocal as to how we can improve this transition of care, interventions
that support patient involvement may be more effective. The ‘Your Care Needs You’ (YCNY) intervention supports
patients to ‘know more’ and ‘do more’ whilst in hospital in order that they better understand their health condition
and medications, maintain their daily activities, and can seek help at home if required. The intervention aims to
reduce emergency hospital readmissions and improve safety and experience during the transition to home.
Methods: As part of the Partners At Care Transitions (PACT) programme of research, a multi-centred cluster
randomised controlled trial (cRCT) will be conducted to explore the feasibility of the YCNY intervention and trial
methodology. Data will be used to refine the intervention and develop a protocol for a definitive cRCT.
Ten acute hospital wards (the clusters) from varying medical specialties including older peoples’ medicine, trauma
and orthopaedics, cardiology, intermediate care, and stroke will be randomised to deliver YCNY or usual care on a
3:2 basis. Up to 200 patients aged 75 years and over and discharged to their own homes will be recruited to the
study. Patients will complete follow-up questionnaires at 5-, 30-, and 90-days post-discharge and readmission data
up to 90-days post-discharge will be extracted from their medical records.
Study outcomes will include measures of feasibility (e.g. screening, recruitment, and retention data) and processes
required to collect routine data at a patient and ward level. In addition, interviews and observations involving up to
24 patients/carers and 28 staff will be conducted to qualitatively assess the acceptability, usefulness, and feasibility
of the intervention and implementation package to patients and staff. A separate sub-study will be conducted to
explore how accurately primary outcome data (30-day emergency hospital readmissions) can be gathered for the
definitive cRCT.
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Discussion: This study will establish the feasibility of the YCNY intervention which aims to improve safety and
experience during transitions of care. It will identify key methodological and implementation issues that need to be
addressed prior to assessing the effectiveness of the YCNY intervention in a definitive cluster randomised controlled
trial.
Trial registration: UK Clinical Research Network Portfolio: 42191; ISTCRN: ISRCTN51154948. Registered 16/07/2019.
Keywords: Transitions of care, Discharge, Cluster randomised controlled trial, Hybrid interventions, Feasibility trial,
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Background
For older people and those with complex needs, the tran-
sitional period of moving from hospital to home poses
various risks [1, 2]. As many as one in five patients experi-
ence an adverse event during this time, 62% of which
could be prevented or ameliorated [3]. In recent years,
emergency readmission rates have increased by 23% with
around 30% of all readmissions estimated to be avoidable
[4–6]. As older people are the highest users of the Na-
tional Health Service (NHS) in the United Kingdom (UK),
they represent an important target for support to improve
transitions of care.
A recent meta-analysis of 92 randomised controlled trials
(RCTs) of interventions to improve transitional care for
older people observed a significant reduction in hospital
readmissions at multiple time points up to 12months post-
discharge [7]. The existing interventions are all highly com-
plex, adopting multiple and variable components, commen-
cing, and ending at different time-points. As a
consequence, deciphering which components are the active
ingredients is challenging [8–10]. There is some suggestion
however that interventions which seek to enhance patient
capacity to reliably access and enact post-discharge care are
effective [11, 12]. Supporting patient involvement aligns
with the patient’s and carer’s position as the common de-
nominator throughout the care pathway. Patient involve-
ment in care during the hospital stay may be a key
mechanism for enhancing patients’ capacity to ‘reach-in’ to
the health care system enabling them to optimise their care
[13]. The mechanism for doing this however has not been
fully explored.
To address this knowledge gap, the Partners At Care
Transitions (PACT) programme of research explores
whether greater involvement of older patients and their
families during the hospital stay can improve patient ex-
perience and safety at transitions of care. Through our
earlier work, we have modelled transitional care to iden-
tify four key ‘functional aims’ or activities for which pa-
tients are responsible for (to varying degrees) once they
are discharged home [14]. These include:
 Managing their health and wellbeing so that they
understand what care they received in hospital and
resume responsibility (as appropriate) for this at
home;
 Managing their medications so that they have the
knowledge and skills required to understand and
take their medications correctly;
 Managing their daily activities to retain autonomy
and minimise the effects of deconditioning;
 Escalating their care needs in an appropriate and
timely manner.
Guided by our aim to explore patient involvement, we
developed a ‘theory of change’ as to how transitions of care
may be improved for older people [14]. We posit that sup-
porting older people while they are in hospital to ‘practice
being at home’ will better prepare them to manage these
four functional activities at home. However, without sup-
port, patient involvement, particularly for older people,
might be problematic and inconsistent. Patients themselves
can fluctuate in how and when they want or are able to be
involved, and busy staff may fail to recognise or engage with
patient’s attempts to be involved [15].
Based on these principles, we co-designed an intervention,
called ‘Your Care Needs You’ (YCNY), which aims to sup-
port older patients and carers to ‘know more’ and ‘do more’
whilst in hospital in relation to the identified four key func-
tional aims. The resulting intervention aligns with emergent
thinking about the development of complex interventions
which focus on standardising interventions according to their
functional aims rather than their form (i.e. specific compo-
nents) [16]. Building on this, YCNY can also be regarded as
a ‘hybrid’ intervention whereby certain components of an
intervention are fixed, while others can vary according to the
context within which they are implemented [17].
Methods
Study aims and objectives
This study aims to explore the feasibility of the YCNY
intervention and trial methodology. In particular, the
study will explore:
1. The acceptability, usefulness, and feasibility of
intervention components and the implementation
package to patients, carers, and staff;
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2. The feasibility of methods to identify, recruit, and
retain patients in the trial and to determine the best
way to follow up patients in this population;
3. The required approaches for obtaining health
economic data, ward level baseline data, and
accurate routinely collected hospital emergency
readmission data;
4. How intervention fidelity might be measured in the
definitive cRCT.
Ultimately, findings from the study will be used to re-
fine the intervention and inform the development of a
protocol for the definitive cRCT in which the effective-
ness and cost-effectiveness of YCNY will be assessed.
Study design
A cluster randomised controlled feasibility trial will be
conducted on ten wards (the clusters) within three acute
NHS Trusts in the Yorkshire and Humber region of the
UK. Cluster designs are used when there is a significant
risk of contamination occurring if individual patients
within a ward were randomised. Since this study in-
cludes a ward level component, it was not possible to
use individual randomisation. Wards will be randomised
to deliver either the YCNY intervention or usual care.
A minimum of 200 patients (20 per ward) will be re-
cruited across intervention and control wards to
complete questionnaires at baseline and then three time-
points following discharge from hospital—5- to 14-, 30-,
and 90-days post-discharge. Routine data regarding the
patients’ index hospital admission and any subsequent
readmissions (up to 90-days post-discharge) will be ex-
tracted from their medical record.
An embedded qualitative evaluation will assess the
feasibility and acceptability of the intervention and im-
plementation package. Up to 24 patients and their carers
will be recruited from intervention wards to participate
in patient-level observations of care and individual inter-
views. Up to 28 staff will be recruited to participate in
interviews and ward-level observations.
In addition, a sub-study will be conducted alongside
the feasibility trial to explore the most efficient, cost-
effective, and accurate way of gathering primary out-
come data (30-day emergency hospital readmissions)
within the definitive cRCT. Approval has been sought
from the Confidentiality Advisory Group (CAG) to ac-
cess the medical records of 100 patients (10 per ward)
without consent to understand the actual destinations of
patients who are discharged to their ‘usual place of
residence’.
Figure 1 details the schedule of study enrolment, inter-
ventions, and assessments. The SPIRIT checklist [18],
which details the recommended items to include in a
clinical trial protocol, is available in Additional file 1.
Setting
The feasibility trial will be conducted across a range of
specialties including older peoples’ medicine, trauma
and orthopaedics, cardiology, intermediate care, and
stroke. Eligible wards will be NHS funded, inpatient hos-
pital wards where approximately 40% or more of pa-
tients are routinely aged 75 years and over. Acute
medical admission wards, wards without regular medical
input, and/or those currently participating in a trial will
be excluded. NHS Trust and ward level agreement will
be gained for eligible wards to participate in the study.
Randomisation
The randomisation will be carried out remotely by a
statistician at the York Trials Unit (YTU), University of
York who is not involved in the recruitment of wards or
the enrolment of participants. Clusters (wards) will be
randomised in an unequal allocation ratio (3:2) via mini-
misation using minimPy [19] (intervention n = 6; control
n = 4). An unequal allocation ratio will ensure robust
data for exploring the feasibility and acceptability of the
intervention across a representative range of specialties.
Naïve minimisation with a base probability 1.0 (i.e. de-
terministic minimisation) will be conducted using three
key ward characteristics: ward specialty; percentage of
patients aged 75 years and over; and NHS Trust. The
wards will be informed of which arm they have been al-
located by a member of the research team. The unequal
allocation of wards prevents blinding of the treatment
group.
Patient population and sample size
Up to 10 wards (clusters) will be recruited to the study
based on the need to have at least four clusters per arm
to allow for basic statistical analysis [20]. As this is a
feasibility trial, we did not undertake a formal sample
size calculation. Based on previous experience of recruit-
ment rates for older people in a recently completed trial
[21] and to ensure that we will have sufficient numbers
to explore the feasibility and test the intervention, we
considered a minimum of 200 patients (20 per ward)
would be sufficient. The assumptions underpinning this
sample size will be assessed through the study. Eligible
patients will be 75 years and over; anticipated to be dis-
charged to their own home or that of a relative; staying
for at least one night on a participating ward; able to
read and understand English; and willing and able to
give informed consent. If a patient lacks capacity, a per-
sonal consultee will advise on their wishes to participate.
Patients will be considered ineligible if they live out of
the area or plan to be transferred to another acute hos-
pital, are admitted for psychiatric reasons (other than
dementia/delirium), or are identified as being at the end
of life.
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The Your Care Needs You (YCNY) intervention
Intervention components
The intervention comprises three fixed core
components:
YCNY booklet This patient-facing booklet is given to
patients at the start of admission to a participating ward
and is designed to be used throughout their stay and fol-
lowing discharge. Focusing on the four key functions,
the booklet provides information as to why patients
should ‘know more’ and ‘do more’ in hospital and gives
suggestions as to how they could do this. The booklet
contains ‘I would like to talk about’ pages which patients
can use to indicate to staff that there is something they
would like to discuss. There are spaces for patients,
carers, or staff to make notes.
YCNY film Where possible, a short educational film will
be shown to patients when introducing the booklet. The
film brings to life and seeks to underline our hypothe-
sised links between retaining and supporting cognitive
capability and physical capacity within the hospital, and
Fig. 1 The schedule of enrolment, interventions, and assessments [as per Standard Protocol Items: Recommendations for Interventional Trials
(SPIRIT)] [18]
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better outcomes post-discharge. The web address of the
film is publicised within the booklet so that carers/pa-
tients can also view it independently.
Care summary At discharge, patients will receive a
patient-friendly care summary, written in lay termin-
ology, to help them understand why they have been in
hospital, any changes to their medication, what to expect
following discharge, and when and how to escalate care
if needed. This letter will supplement rather than replace
existing discharge letters which are sent to a patient’s
General Practitioner (GP). Template letters will be pro-
vided for wards to flexibly implement according to their
ward context.
In addition to these fixed core components, ward staff
will be asked to consider how they currently support pa-
tient involvement with respect to the four key functions
and what else they can do to enhance this. The actions
that the teams decide to undertake will not be pre-
scribed—they will be left to vary according to staff pref-
erences, current activities/initiatives on the ward that
already address the four functions, and their patient
population.
Implementation
The implementation of YCNY will be supported in four
ways.
A facilitation meeting, lasting 1–2 h, will be held with
key staff members (e.g. ward manager, nurses, healthcare
assistants, discharge coordinator, therapists, and doc-
tors/consultants) to discuss delivery of the intervention
within each wards’ specific context. Through the meet-
ing, staff will (i) decide how to deliver the core interven-
tion components; (ii) map what they currently do to
meet the four functional aims; and (iii) think of add-
itional tools or initiatives that they could use to meet
these aims. A coach(es) will be identified whom the re-
search team can work more closely with, and who can
act as a point of contact for ward staff as needed.
Deciding on staff roles—To help the intervention fit
into each ward’s specific context, the roles that staff
groups will fulfil will vary. The roles required include
introducing the YCNY booklet, showing the patient film,
encouraging patient use of the booklet, and responding
to patient questions. Roles will be discussed and allo-
cated during the facilitation meeting.
Staff training will be delivered to multidisciplinary staff
to ensure that they have knowledge of, understand the
benefits of, and have the skills required to deliver the
intervention. Training will be delivered through two
principal routes: (i) fuller briefings about the interven-
tion at extended multidisciplinary team meetings, staff
handovers, or using ad hoc opportunities/drop-in ses-
sions; and (ii) briefing and support for those involved in
delivering specific intervention components (e.g. the care
summary). Posters and handouts will help remind and
support staff to interact with the booklet.
A ‘share and learn’ session will be held 2–3 weeks after
the ward has started implementing the intervention. The
session aims to identify and resolve any problems en-
countered in delivering the core intervention compo-
nents, to reflect on how the booklet/film may have
influenced patient behaviours (e.g. requesting to practice
their medications) and to discuss how the team have
and could respond to meet the functional aims of the
intervention.
Control wards
Control wards will deliver usual care to their patients ac-
cording to their Trust’s standard policies and proce-
dures. Researchers will arrange short briefing sessions
with the ward manager to inform the ward staff of the
study activity and patient recruitment.
Recruitment and consent
Recruitment will commence once ward teams have
started to implement the intervention. A discretionary
period of up to a month may be used to embed the
intervention in the ward. Exact start dates for recruit-
ment will vary by Trust and ward depending on when
NHS Trust permissions are received and implementation
is agreed at ward level. Recruitment is expected to take
up to 4months.
Screening and identification
Suitably qualified ward staff will screen and identify eli-
gible patients. All patients aged 75 years and over will be
screened for eligibility. Detailed screening logs will rec-
ord numbers of eligible patients, key reasons for ineligi-
bility, and recruitment/refusal rates. Screening data will
be used to complete a CONSORT diagram for cluster
trials [22].
Approach and consent
In addition to screening patients against the study’s in-
clusion and exclusion criteria, staff will be asked how
and when eligible patients should be approached (e.g.
whether they are well enough). Researchers will provide
eligible patients with written information and a verbal
explanation of the study (see Additional file 2 for an ex-
ample). Patients will have an opportunity to ask ques-
tions and consider their participation. If patients wish to
take part, a written (or witnessed) consent form will be
completed. A letter will be sent to the patient’s GP to in-
form them of their participation.
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Patients who lack capacity
A significant proportion of patients within this older
population (75 years and over) are likely to lack the cap-
acity to make decisions about their care. These patients
are often more vulnerable to safety incidents and/or
poorer experience during transitions of care [21]. To be
as inclusive as possible, it is important that this particu-
lar patient population is included in the study. Capacity
will be assessed during the screening process and the
initial approach. If patients lack capacity, attempts will
be made to identify and recruit an informal carer (e.g.
family member or friend) who can act as a personal con-
sultee for the patient. A written declaration will be
gained from all participating consultees.
Withdrawal
The rights of patients and consultees to withdraw from
the study will be respected. They can do so without giv-
ing a reason and without their care or treatment being
affected. Data previously collected will be used in ana-
lyses (unless consent for this is withdrawn) and, where
possible, a reason for withdrawal will be recorded. If pa-
tients are unexpectedly discharged from the hospital into
24-h care such as nursing/care homes (other than for a
temporary period of rehabilitation), they will become in-
eligible and will be withdrawn.
Outcomes
The main outcomes for this study are process-based, as
the study aims to assess the feasibility of YCNY and the
trial methodology, rather than the effectiveness of the
intervention. Outcomes, therefore, include measures of
feasibility namely: (i) screening, recruitment, and reten-
tion data; (ii) the processes required to collect accurate
data from consented patients, routine medical records,
and the ward (via information services); (iii) the ap-
proach required to collect health economic data; and (iv)
qualitative data relating to the acceptability of YCNY
and feasibility of implementing it. Patients will be asked
to complete a number of validated measures which are
outlined in the section below.
Data collection
Data will be collected at the level of the patient and the
ward through a mix of self-report and routinely collected
data.
Patient baseline questionnaires
Following recruitment, researchers will support patients
to complete a baseline questionnaire. This includes basic
demographic information, contact details to conduct
post-discharge follow-ups, the Barthel Index [23],
EQ5D-5 L [24], and the Functional Comorbidity Index
[25] (all validated measures are outlined in Table 1).
Most data will be self-reported by patients or consultees
but, where this is not possible, data will be gathered via
staff or from patient medical records.
Patient post-discharge follow-up questionnaires
Following discharge from hospital, patients will be sent
postal questionnaires at three time points—5-, 30-, and
90-days post-discharge. These time points represent a
critical safety period (immediately post-discharge), are
policy-relevant (30-days), and allow assessment of
longer-term effects (90-days). To try and increase re-
sponse rates, patients will receive a £5 voucher with the
questionnaire at each time point [29]. Measures include
the Partners At Care Transitions Measure (PACT-M)
[26], Care Transitions Measure (3 items—CTM-3) [27],
EuroQol 5-Dimension Health Questionnaire (5 levels)
(EQ5D-5 L) and Proxy EQ5D-5 L [24], and the adapted
Client Service Receipt Inventory (CSRI) [28] (see Table
1 for further details). Questions will also be asked to as-
sess receipt and thereafter, the usefulness of the
intervention.
Figure 2 outlines the process for collecting post-
discharge follow-up data. Patients will choose to be
followed up by post alone or to additionally receive tele-
phone support. Those choosing the latter will be tele-
phoned approximately 3 days after the first postal
questionnaire is sent. If questionnaires are not returned,
a postal reminder will be sent 10 days later and a final
attempt to collect data will be made via telephone to all
patients regardless of follow-up choice. We will attempt
to collect data at each time point unless patients expli-
citly withdraw from the study. The mortality status of
patients will be checked prior to each follow-up time
point.
Patient-level routine data
In addition to the self-report data outlined above, rou-
tine data will be extracted from the consented patients’
medical records. Data includes:
 Recorded discharge date for the index admission—to
ensure accurate discharge dates are recorded during
the trial;
 Emergency hospital readmission dates up to 90-days
post-discharge—to assess the feasibility of collecting
our primary outcome measure in the definitive
cRCT, and to calculate the length of stay for any
readmissions;
 Ward moves that occurred prior to discharge during
index admission—to assess intervention fidelity and
contamination between wards.
Due to funding and progression of the PACT
programme of work, the research team face tight
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timescales between finishing the feasibility trial and
starting the definitive trial. As this study does not assess
effectiveness, if the Trial Management Group decide that
we already have enough data to assess the feasibility of
progressing to a definitive trial, we may decide not to
collect questionnaire and routine readmission data up to
the full 90-days post-discharge for patients who are re-
cruited later in the study.
Ward-level routine data
To explore what ward level baseline data are required
for the definitive cRCT, the following non-identifiable
data will be extracted for each participating ward over
the most recent 12-month period:
 The total number of patients discharged from a
participating ward and the total number of these
patients who are readmitted to the hospital Trust
(any ward) within a 30-day period (split by patients
who are < 75 years and ≥ 75 years);
 Average length of stay for patients admitted to each
participating ward (split by patients who are < 75
years and ≥ 75 years with monthly totals);
In addition, the total number of admissions to partici-
pating wards during the recruitment period (split by <
75 years and ≥ 75 years) will be used to identify how
many patients aged 75 years and over were admitted to
the ward but not screened.
Statistical analysis
A full statistical analysis plan will be drafted before the
completion of data collection. Quantitative analysis will
focus on descriptive summaries for each treatment
group including the number of wards and patients
approached, randomly assigned, receiving intended
treatment, and providing outcome data. A CONSORT
diagram for cluster trials will document the flow of par-
ticipants through the study. The percentage of partici-
pants readmitted will be determined. The degree of
clustering using intracluster correlation coefficients
(with 95% confidence intervals) may also be quantified,
acknowledging that this may be unreliable due to the
small sample size [30].
Participant withdrawals, reasons for withdrawal, and
non-responses at each data collection point will be
summarised and compared by trial arm. Recruitment
and attrition rates (ward and patient) across the two
arms will be compared, along with outcomes data at
follow-up. All baseline and outcome data will be sum-
marised descriptively by trial arm using means and
standard deviations for continuous variables and
counts and percentages for categorical data. Partici-
pants will be summarised by their randomised ward
irrespective of whether they received the actual allo-
cation or not. PACT-M data will also be analysed to
define cut-offs for a high versus low-quality transition.
There are no planned interim analyses.
Qualitative and quantitative data will be used to assess
the following criteria when deciding whether to progress
to a definitive cRCT:
– 2–8 eligible wards exist within participating trusts
(depending on size) and narrative indications of staff
interest
– Average of 4 patients per ward per month recruited
– Attrition less than 10% for the primary outcome
Table 1 Validated measures collected from patients at baseline and during post-discharge follow-ups
Measure Description Collected when
Functional Co-morbidity Index (FCI) [25] 18 self-reported comorbid conditions with a score of 0 to 18 with each item scoring 1. A
higher FCI score indicates greater comorbidity and is associated with impairment in physical
function 1 year later.
Baseline
Barthel Index (BI) [23] 10 items measuring a person’s daily functioning, particularly the activities of daily living and
mobility. Total possible scores range from 0 to 20, with lower scores indicating increased
disability.
Baseline
EuroQol 5-Dimension Health Questionnaire (5
levels) (EQ5D-5 L) & Proxy EQ5D-5 L [24]
The EQ5D-5 L and Proxy EQ5D-5 L measures quality of life comprising five dimensions: mobil-
ity, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is
scored on a five-point ordinal scale: no problems, slight problems, moderate problems, severe
problems, unable. Scores can be used to calculate quality-adjusted life-years (QALYs).
Baseline and post-
discharge follow-ups
Partners At Care Transitions Measure (PACT-M)
[26]
The PACT-M assesses patient perceptions of the quality and safety of transitions from hospital
to home, relevant to a UK population. In total, eight items are scored on a five-point Likert
scale: strongly disagree, disagree, neither agree nor disagree, agree, strongly agree with an
additional option of ‘not applicable’. The PACT-M also measures the incidence (yes or no) of
seven adverse events following discharge from the hospital.
Post-discharge
follow-ups
Care Transitions Measure 3 items (CTM-3) [27] The CTM-3 (derived from the 15-item CTM) is a patient-centred measure of the quality of care




Client Service Receipt Inventory (CSRI) [28] The CSRI will be used to assess patients’ use of health-related resources. Questions have been
adapted to assess the health resources that are pertinent to care transitions from hospital to
home for older people.
Post-discharge
follow-ups
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– Staff, patients, and carers positively evaluate the
intervention (or modifications can be made to
address any concerns).
Fulfilment of these progression criteria will be dis-
cussed and agreed with our Trial and Programme Man-
agement Groups, our independent Trial Steering
Committee, and the funders (the National Institute for
Health Research).
Embedded qualitative assessment of feasibility
Qualitative methods will be embedded within the feasi-
bility study to explore the acceptability, usefulness, and
feasibility of the intervention, and explore how fidelity
can be assessed.
Sample
On intervention wards, purposive and opportunity sam-
pling will be used to recruit a nested sample of 20–24
Fig. 2 Process for collecting post-discharge follow-up data
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patients (3–4 patients per ward). Patients will consent to
patient-level observations and interviews in addition to
the quantitative post-discharge follow-ups. Carers (e.g.
spouse or child) who are involved in a patient’s care will
also be recruited to participate. Patients will receive up
to £30 as a thank you for their participation.
Multidisciplinary staff involved in the facilitation meet-
ings and implementing the intervention will be purpos-
ively sampled to participate in interviews and/or ward-
level observations. In addition, one staff member on each
control ward will be recruited at the end of the study to
participate in an interview (n ≤ 28).
Data collection methods
Interviews Semi-structured interviews will be conducted
with patients, carers, and staff to explore acceptability,
usability, usefulness, and feasibility of the intervention
components (both fixed and flexible) and to explore how
implementation worked within the ward context. Sug-
gestions about optimising the intervention and imple-
mentation package will be gathered. Patient interviews
lasting 30–60min will take place just after discharge and
will be conducted either at the patient’s home or over
the telephone. If patients continue to use the interven-
tion at home, a second interview will be conducted at
30-days post-discharge. Staff interviews will last 15–30
min. Interviews with staff on control wards will explore
any activities that are similar to those that would meet
the functional aims of the intervention (e.g. End PJ Par-
alysis Initiatives) and thus appear to ‘dilute’ the effect of
the intervention, or serve as evidence of contamination.
Interviews will be audio-recorded where possible, other-
wise, detailed field notes will be taken.
Observations Patient- and ward-level observations will
explore how patients, carers, and staff interact with the
intervention during the patient stay and at discharge.
Patient-level observations will include the introduction
of the booklet, occasions where staff and patients inter-
act as part of routine care (e.g. ward and medicine
rounds), and at discharge. Ward-level observations are
likely to include the facilitation session and support re-
quired to embed the intervention, staff training, staff
roles in using the booklet, and ward level activities (e.g.
daily cares, ward rounds, medication rounds, meetings,
briefings, and handovers). Observations will be captured
through field notes and ‘contact summary forms’ will be
completed for each ‘contact’ (e.g. a discrete piece of ob-
servation, or something less bounded such as a day
spent observing ward activity).
Documentary analysis All participants who consent to
the quantitative arm of the feasibility trial will be asked
at the 30-day post-discharge follow-up if they received a
YCNY booklet in hospital and, if so, whether they would
be willing to return it to the research team. Any
returned booklets will be analysed to explore how they
have been used.
Qualitative data analysis
Qualitative data will be analysed using a ‘pen portrait’
method [31]. Pen portraits are typically used to synthe-
sise data across sources. Data related to each ward will
be drawn together to describe how the intervention was
implemented, how staff and patients engaged with the
intervention, and what the experience was for patients
following discharge. Pen portraits will subsequently form
the unit of analysis and be subjected to a thematic ana-
lysis [32], before being synthesised, with coding specific-
ally pertaining to issues of acceptability and feasibility.
Sub-study to assess discharge destinations
The target patient population for this programme of
work is older people who transition from hospital back
into their own home (rather than 24-h care, e.g. a nurs-
ing or care home). To test the effectiveness of the inter-
vention in the definitive cRCT, primary outcome data
(30-day emergency readmissions) are required from
7000 patients which we had planned to gather at a ward
level via routinely collected administrative data. How-
ever, our previous work has highlighted that patients are
coded as being discharged to their ‘usual place of resi-
dence’ which does not distinguish those who go from
and to their own homes (our target population) and
those who go from and to 24-h care/nursing homes. Not
understanding the size of this coding problem represents
a major threat to the internal validity of the definitive
trial. As such, a separate sub-study will explore the ac-
tual discharge destinations of patients on participating
wards who are aged 75 years or over and are coded as
being discharged to their ‘usual place of residence’.
Confidentiality Advisory Group permissions have been
gained to access patient medical records without con-
sent. Trusts will identify a consecutive sample of 10 pa-
tients from each participating ward who are aged 75
years and over and have been coded as discharged to
their ‘usual place of residence’. Their medical records
will be accessed to identify their actual discharge address
and this will be categorised as being either: their own or
a relative’s home; a nursing or care home; intermediate
care; or other. The research team will receive anon-
ymised, aggregated ward-level data detailing the total
number of patients discharged to each category.
Data management, monitoring, and safety reporting
Patient data will be recorded on case report forms
(CRFs). Participants will be assigned a unique
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identification number and all data will be completely
anonymised for purposes of analysis and reporting. Elec-
tronic data and wet ink copies of the CRFs will be stored
securely at YTU. Data will be monitored for quality and
completeness by YTU. Missing data, except that from
post-discharge follow-ups, will be chased until they are
received or confirmed as not available. Most data will be
collected directly from participants and so cannot be
subject to data verification. All qualitative data and con-
sent forms will be held securely by the Yorkshire Quality
and Safety Research Group (YQSR) at the Bradford In-
stitute for Health Research.
The trial is overseen by the Trial Management Group
(TMG) comprising of the chief investigator, key co-
applicants, and the operational members of YQSR and
YTU. An independent Trial Steering Committee (TSC) and
Data Monitoring Committee (DMC) comprising academic,
NHS England, clinical, and a patient representative meet
annually. Further details are available on request.
In this patient population, acute illness, deterioration of
health, and readmissions are likely and so will not be re-
ported during this study. The death of participants is also
expected. All expected and unrelated deaths will be re-
ported to the TMG and reported annually to the REC and
TSC/DMC. Any unexpected and related serious adverse
outcomes will be reviewed by the chief investigator and re-
ported to the sponsor and ethics committee.
Trial organisation and administration
The feasibility study is being conducted as part of a five and
a half year Programme Grant for Applied Health Research
(RP-PG-1214-20,017) funded by the National Institute for
Health Research. The trial is sponsored by Bradford Teach-
ing Hospitals NHS Foundation Trust and is coordinated by
YQSR at the Bradford Institute for Health Research, and
YTU at the University of York.
Approvals were gained from the Wales Rec 7 Research
Ethics Committee, Confidentiality Advisory Group, and
the Health Research Authority prior to starting the study
(REC reference [19]/WA/0162, CAG reference [19]/
CAG/0105). Local NHS capability and capacity ap-
provals were granted by all participating NHS Trusts.
Any amendments to the protocol will be submitted for
the required regulatory approval. The study is registered
on the UK Clinical Research Network Study Portfolio
(42191) and the ISTCRN (ISRCTN51154948).
Patient and public involvement
The PACT programme grant has an active patient panel
who have been involved in co-designing the YCNY interven-
tion, and have advised and supported the development of
study procedures and documents. Panel members will be in-
volved in the analysis, dissemination of results, intervention
iteration, and protocol development for the definitive cRCT.
Dissemination
Findings will contribute to the on-going progression of
the PACT programme of work. They will be dissemi-
nated widely to a broad audience including academics,
clinicians, healthcare managers, policymakers, and pa-
tients and the public and participants within the study.
The findings will be written up for publication in peer-
reviewed journals and will be presented at national and
international conferences, workshops, and learning
events.
Discussion
Transitions from hospital to home can be risky, particu-
larly for older people who often have complex health
and/or social care needs [3]. Although the evidence is
equivocal, there is some suggestion that interventions
that support patient involvement may improve transi-
tional care outcomes [10, 12]. The PACT programme of
research, therefore, asks whether supported involvement
of older patients and their families in their care improves
patient experience and safety at transitions of care.
Through our earlier work [14, 33, 34], we have designed
an intervention which supports patients to ‘know more’
and ‘do more’ during their hospital stay so that they can
manage their care at home post-discharge. The present
study assesses the feasibility of delivering this interven-
tion and the trial methodology in order to refine the
intervention and protocol for a definitive cRCT trial. As
with any complex intervention various challenges out-
lined below are anticipated throughout the study.
Recruitment
The study will assess the feasibility of implementing the
intervention and recruiting patients on different types of
the ward (i.e. different acute specialties). It may be that
some specialties (e.g. stroke care) are less suited due to
their specified patient pathways, provision of extensive
post-discharge rehabilitation, and/or low patient turn-
over. Further to this, patient movement between inter-
vention, control, and other hospital wards prior to
discharge will be assessed in order to explore issues of
contamination and fidelity.
Post-discharge follow-ups
Challenges are also anticipated when conducting post-
discharge follow-ups. First, the study team will be reliant
on participating Trusts regularly tracking patient dis-
charges to trigger the processes for post-discharge
follow-ups. Patients who are discharged to their home
address may do so via a different address. Some of this
variation will be observed by tracking discharge destina-
tions (e.g. to intermediate care beds) but some of it may
not (e.g. if a patient temporarily stays at a relative’s
home). The proportion of unreturned questionnaires
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due to non-receipt by the patient or another reason may
remain unknown. Second, over recent years, the lengths
of hospital admissions have reduced [35] and so patients
are increasingly going home with ongoing care needs
such as wound care management or medication moni-
toring. Collecting data during the initial post-discharge
period when patients may still be unwell and/or particu-
larly vulnerable to hospital readmissions [36] may im-
pact our CRF return rates. Third, retention and attrition
will need to be monitored as follow-ups are being con-
ducted up to 90-days post-discharge. Up to 15% of pa-
tients are likely to be readmitted within 30 days [37]
which is likely to impact patients’ ability to respond to
questionnaires accurately and within the necessary time
frames. In addition, attrition is expected as people re-
quest to withdraw or become lost to follow-up. Death
within this older patient population is also expected dur-
ing the follow-up period.
Implementation
A key aim of this study is to assess the feasibility of the
intervention and implementation package. The qualita-
tive evaluation will be conducted to monitor the use of
the intervention by staff, patients, and carers in order to
identify barriers and enablers. These data will be used to
refine the YNCY intervention and implementation pack-
age used in the definitive trial. As hybrid interventions
are relatively novel within health services research [17],
the qualitative data will also be of particular importance
in guiding the research team on how they can support
flexible implementation within the confines of a cRCT
study design.
Trial status
This article refers to protocol version 3 dated 19/11/2019.
Recruitment began on 15/11/2019 with completion ex-
pected by the end of March 2020. Post-discharge data col-
lection is due to finish in June 2020.
This feasibility trial will support the identification of key
methodological issues that will be faced when implement-
ing and assessing the effectiveness of the YCNY interven-
tion. The results of the study will be used to develop a
protocol for the definitive cRCT which is due to commence
in the summer of 2020.
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